Is iPLA2β a Novel Target for the Development of New Strategies to Alleviate Inflammatory Bowel Disease?
- 21 September 2015
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (12) , 3504-3506
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Calcium-independent phospholipases A2 and their roles in biological processes and diseasesJournal of Lipid Research, 2015
- Deficiency of Group VIA Phospholipase A2 (iPLA2β) Renders Susceptibility for Chemical-Induced ColitisDigestive Diseases and Sciences, 2015
- Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5′-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-CellsJournal of Biological Chemistry, 2015
- The role of PGE2 in intestinal inflammation and tumorigenesisProstaglandins & Other Lipid Mediators, 2015
- The cell biology of the intestinal epithelium and its relation to inflammatory bowel diseaseThe International Journal of Biochemistry & Cell Biology, 2013
- Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic InterventionChemical Reviews, 2011
- Intestinal homeostasis and its breakdown in inflammatory bowel diseaseNature, 2011
- Recent progress in phospholipase A2 research: From cells to animals to humansProgress in Lipid Research, 2011
- Group VIA Ca2+-independent phospholipase A2 (iPLA2β) and its role in β-cell programmed cell deathBiochimie, 2010
- Biochemistry and Physiology of Mammalian Secreted Phospholipases A2Annual Review of Biochemistry, 2008